HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zongyang Liu Selected Research

Ilexhainanoside D

10/2019The combination of Ilexhainanoside D and ilexsaponin A1 reduces liver inflammation and improves intestinal barrier function in mice with high-fat diet-induced non-alcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zongyang Liu Research Topics

Disease

2Non-alcoholic Fatty Liver Disease
10/2019 - 02/2018
1Arteriovenous Fistula
03/2024
1Erythema
09/2023
1Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
09/2023
1Skin Diseases (Skin Disease)
09/2023
1Inflammation (Inflammations)
10/2019

Drug/Important Bio-Agent (IBA)

2SaponinsIBA
10/2019 - 02/2018
1ThrombomodulinIBA
03/2024
1Platelet Activating FactorIBA
03/2024
1P-SelectinIBA
03/2024
1Ointments (Pastes)IBA
09/2023
1EmollientsIBA
09/2023
1Gentamicins (Gentamicin)FDA LinkGeneric
09/2023
1Nonsense Codon (Nonsense Mutation)IBA
09/2023
1TriterpenesIBA
10/2019
1ilexsaponin A1IBA
10/2019
1Ilexhainanoside DIBA
10/2019

Therapy/Procedure

1Oral Administration
02/2018